Regulus Therapeutics Inc. buy SVB Leerink LLC
Start price
18.03.24
/
50%
€2.10
Target price
18.03.25
€5.51
Performance (%)
-21.43%
Price
29.08.24
€1.47
Summary
This prediction is currently active. The prediction for Regulus Therapeutics Inc. disappoints with a performance of -21.43%. This prediction currently runs until 18.03.25. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Regulus Therapeutics Inc. | 4.895% | 4.895% |
iShares Core DAX® | 2.147% | 2.681% |
iShares Nasdaq 100 | -0.578% | -0.816% |
iShares Nikkei 225® | 0.635% | 3.079% |
iShares S&P 500 | 0.746% | 0.171% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Regulus Therapeutics Inc. diskutieren
Regulus Therapeutics Inc. (NASDAQ: RGLS) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $6.00 price target on the stock.
Ratings data for RGLS provided by MarketBeat